Navigation Links
Cancer Patients Prone To Developing Blood Clots

Cancer patients who receive treatment might have a greater risk of developing blood clots say researchers, // however a new study shows many doctors are not taking the necessary steps to prevent the clots from forming.

Researchers surveyed more than 100 oncologists to determine if the doctors were aware of the risk of blood clots and to evaluate preventative measures used by the physicians. About 40 percent of the doctors who were surveyed treated their patients with either chemotherapy or radiotherapy, and less than 10 percent said they used hormone therapy on their patients.

Results of the study showed more than 90 of the 160 doctors surveyed thought radiotherapy posed little or no increased risk for blood clots. More than 80 doctors thought the same for chemotherapy, and more than 70 agreed hormone therapy did not increase the risk.

Of the doctors surveyed, 84 did not routinely recommend blood thinners, such as aspirin or warfarin, as a preventative measure for patients treated with chemotherapy. Seventy-nine doctors did not recommend the medication for hormone therapy patients, and 86 did not advise radiotherapy patients to use the blood thinners. Nearly 40 percent of the oncologists said less than 1 percent of their patients were currently using prophylactic measures for preventing blood clots.

Researchers conclude saying health care professionals need to be better educated about the potential increased risk of blood clots in cancer patients.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information

Post Your Comments:
(Date:12/3/2009)...discharged from hospitals on ventilator support an...ths later. Researchers from the Frances Payne Bol...ersity report these findings in American Journal ... only important outcome for patients," says Barbar...utes of Health-funded study, "Composite Outcomes o...
(Date:12/3/2009)...nd other healthcare professionals specialising in ...rt advice to guide them through the complex clinic...demic. , The paper, published online by the Am...m to stay alert to the significant concerns that s...ibly even bird flu (H5N1), to develop into a strai...
(Date:12/3/2009)...ected volunteers from virus linked to cervical can...s) -- The human papillomavirus (HPV) vaccine Cerva...six years, new research has found. , The vaccin...HPV-18) most commonly associated with cervical can...ed 15 to 25, with a normal cervical profile and no...
(Date:12/3/2009)...sive users also feel depressed or anxious when not...News) -- A survey of Chinese adolescents found tha... as likely to harm themselves as other teens. ,...ere living in the Chinese city of Guangzhou in Gua...ey had harmed themselves in some way within the pr...
(Date:12/3/2009)... The Arthritis Foundation bestowed it...ecipients during its national meeting in Atlanta. ...9 -- The Arthritis Foundation bestowed its highest... during its national meeting on Nov. 20 in Atlanta...rding Award for Distinguished Service ,The Arthrit...
Breaking Medicine News(10 mins):Health News:CWRU researchers report poor outcomes for CCI patients leaving hospitals on ventilators 2Health News:Transplant infectious disease experts provide pandemic guidance 2Health News:Transplant infectious disease experts provide pandemic guidance 3Health News:Cervarix Proves Effective Against HPV for Over 6 Years 2Health News:Teen Internet Addicts More Likely to Self-Harm: Study 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4
... Increases Serum Sodium Levels Through Increase in...J., May 21 Otsuka Pharmaceutical Co., Ltd. (OPC) ...alization, Inc. (OPDC) announced today that the U....nts with clinically significant hypervolemic and e...
...la Join effort to Link Services, Caseworkers , , ...n,s Policy, Practice and Research at the Universi...th Montgomery County, Pa., Stewards of Change, Mic...eaking interoperable, real-time technology system ...
...g and Financing Offerings Help Healthcare Provider...bursement Deadlines , , PLANO, Texas, May 21 Pe...tsystems.com ) today announced the availability o...cause of the American Recovery and Reinvestment Ac...
...., May 21: Managed Health Care Associates, Inc. (M... is pleased to announce that Kimberly Binaso-Stwal...American Society of Health-System Pharmacists (ASH...esignated Fellows of ASHP, will be honored during ...
...By combining the expertise of its management liabi...as developed enhanced management liability coverag...hcare organizations, including hospitals, long ter...icy and protects healthcare organizations against ...
...This year 28 students in 17 states have won awards... by the Centers for Disease Control and Prevention... the contest invites fifth- and sixth-grade studen... of the winning posters are at www.fightthebitec...
Other Medicine News:Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 3Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 4Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 5Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 6Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 7Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 8Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 9Health News:University of Pennsylvania, Montgomery County Partner on Integrated, Interoperable System Design for Child Welfare 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 3Health News:MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow 2Health News:MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow 3Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 2Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 3Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 2Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 3
(Date:12/3/2009)... , , SEATTLE and BANGALORE, ...es, a leading provider of software product and app... strategic partnership with,Microsoft BioIT Allian...s.,This will allow players in this rapidly evolvin... development capability, domain knowledge and best...
(Date:12/3/2009)... , , HELSINKI, December 3 /...,and medically proven success in their field, Ligh...cal approval to begin selecting and gene testing,s...e treatment for what the,World Health Organisation...ating and obesity. , A Phase II trial for...
(Date:12/2/2009)... , , NEW YORK, Dec. 2 /PRNewswire/...esearch report is available in its catalogue: ,...tp://www.reportlinker.com/p0164303/Arthroscopes---...opic procedures are on rise, owing to their mounti...of ankles, elbow, wrists, and hips, apart from kne...
Breaking Medicine Technology:Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 61741 1Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 61741 2New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 1New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 1Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 4
Replacement Handle
Replacement Needle Tip
Needle and Gouge Spud Set
Storz Corneal Burr
Medicine Products: